Target intelligence / Profile preview

Sarcoma antigen 3, pseudogene (SAGE3P)

Target
SAGE3P
Molecular classification
Pseudogene, processed pseudogene, non-coding RNA locus
01

Overview

SAGE3P is the sarcoma antigen 3, pseudogene, a genomic element annotated as a pseudogene and presumed to be a non-coding RNA locus. Pseudogenes are gene-like DNA sequences that typically do not encode functional proteins due to accumulated disabling mutations[3]. While some pseudogenes may exert regulatory functions—such as sequestering microRNAs or modulating parental gene expression—SAGE3P is not recognized in key genomic resources as a protein, receptor, enzyme, or validated drug target. There is no documented evidence linking SAGE3P to well-characterized molecular pathways, disease associations, or therapeutic functions, and it is not included in lists of actionable or diagnostically relevant pseudogenes. Its name suggests a relationship to cancer antigens, but this is not supported by functional or clinical data. The use of SAGE3P as a therapeutic target would be considered incorrect under current scientific understanding[3].

Other names
sarcoma antigen 3 pseudogeneSAGE3P
02

Biological functions

OtherPseudogenes are mostly considered to have unknown or regulatory functions; some may act as competitive endogenous RNAs (ceRNAs), modulating the activity of microRNAs and affecting cellular gene expressionNo validated biological functions for SAGE3P specifically are reported in the literature.
03

Disease associations

OtherSome pseudogenes have been implicated in cancer as regulators of gene expression or contributors to genomic instability, but there is no direct evidence for SAGE3P in disease roles“Sarcoma antigen” in its parent gene name may suggest cancer relevance; however, for this pseudogene, this role is highly speculative at best.

Beyond the preview

Go deeper on Sarcoma antigen 3, pseudogene (SAGE3P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sarcoma antigen 3, pseudogene (SAGE3P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call